Skip to content
drillr.ai
Sign up

300110.SZ

Huaren Pharmaceutical Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 2.80
−2.10%
Ask drillr

  • Aug 26, 2026, 10:55 UTC

    Huaren Pharmaceutical reported its first-half 2026 results: revenue of 605 million yuan, down 3.02% year-on-year; net profit attributable to shareholders of 28.5424 million yuan, down 23.55%; non-recurring net profit of 25.4503 million yuan, down 8.09%. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.

    Source:

  • Jul 2, 2026, 08:37 UTC

    Huaren Pharmaceutical appointed Zhang Xinzhong as Vice President.